Women's-Specific Footwear With Prosthetic Feet

NCT03673371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-03-22

No results posted yet for this study

Summary

The purpose of this study is to address footwear challenges unique to women prosthesis users. Comparing the effectiveness of different footwear and prosthesis combinations will help guide clinical decision making regarding the prescription of prosthetic devices, while keeping what the patient wants in mind.

It is expected that these results will be used to generate new knowledge for the development of versatile prosthetic devices that accommodate a user's unique lifestyle while helping the patient to make good progress in rehabilitation.

Investigators will characterize perceived limitations in footwear among women prosthesis users. Investigators think that women prosthesis users will be restricted in footwear choices and clothing choices due to the use of a prosthetic device.

Specifically, investigators expect perceived limitations in footwear will be greater for shoes with higher heels than shoes without heels.

Conditions

  • Lower Limb Amputation Below Knee (Injury)
  • Lower Limb Amputation Above Knee (Injury)

Interventions

OTHER

Questionnaire

This is a questionnaire developed by DoD and VA researchers specifically for this study.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • Minneapolis Veterans Affairs Medical Center

    lead FED

Principal Investigators

  • Elizabeth Russell Esposito, PhD · Extremity Trauma and Amputation Center of Excellence

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-04
Primary Completion
2020-07-22
Completion
2023-01-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03673371 on ClinicalTrials.gov